Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial Evaluating the Safety and Effectiveness of the Intelligently-Driven Signos System for Personalized Weight Management in Overweight and Obese Adults

NCT06214221 is registered in ClinicalTrials.gov with Signos Inc as lead sponsor.

NCT NCT06214221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06214221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial Evaluating the Safety and Effectiveness of the Intelligently-Driven Signos System for Personalized Weight Management in Overweight and Obese Adults
Lead sponsor
Signos Inc
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 2, 2024
Completion date
April 30, 2026
Enrollment
380 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, overweight and obesity, weight loss